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Abstract: Baker’s yeast, Saccharomyces cerevisiae, is the simplest and most well-known 
representative of eukaryotic cells and thus a convenient model organism for evaluating toxic 
effects in human cells and tissues. Yeast cell sensors are easy to maintain with short 
generation times, which makes the analytical method of assessing antifungal toxicity cheap 
and less-time consuming. In this work, the toxicity of test compounds was assessed in 
bioassays based on bioluminescence inhibition and on traditional growth inhibition on agar 
plates. The model organism in both tests was a modified S. cerevisiae sensor strain that 
produces light when provided with D-luciferin in an insect luciferase reporter gene activity 
assay. The bioluminescence assay showed toxic effects for yeast cell sensor of 5,6-benzo-
flavone, rapamycin, nystatin and cycloheximide at concentrations of nM to µM. In addition, 
arsenic compounds, cadmium chloride, copper sulfate and lead acetate were shown to be 
potent non-specific inhibitors of the reporter organism described here. The results from a 
yeast agar diffusion assay correlated with the bioluminescence assay results.  
 
Keywords: Luciferase reporter gene, Photinus pyralis, bioluminescence, rapamycin, toxic 
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1. Introduction 
 
Since the amount of toxic chemicals present in our daily lives is huge and increasing, a sensitive, 
rapid, robust and cheap toxicity assay is needed for acute toxicity assessment in eukaryotic cells. The 
topic has been studied a lot and several biological toxicity tests have been developed. Microbial and 
biochemical tests for assessing chemical toxicity, especially in the aquatic environment, have been 
reviewed by Bitton [1]. Since that time the methods and several models including insect [2], fish [3], 
Daphnia magna [4] and tumor cell lines [5] have been generated for assessing toxicity of molecules to 
eukaryotic cells and tissues. None of these alone can answer the demands for a general model which is 
sensitive, economic and good in predicting the effects of toxic compounds against humans. Model 
organisms of different species typically have different sensitivities, which means that each biological 
test differs more or less from others and may not give universal results when assessing toxicity [6]. 
Additionally, with biological systems, evaluation of toxicity of fat soluble, highly hydrophobic 
compounds is difficult, since these compounds may be underestimated [7]. 
Among yeasts, the well-known baker’s yeast, Saccharomyces cerevisiae, is an excellent organism 
for evaluating genetic functions of more complex eukaryotic organisms, including toxic effects on 
human cells and tissues [8]. Like most yeasts, S. cerevisiae is easy to cultivate and manipulate 
genetically [9] and furthermore, inexpensive and available in all grocery stores. On the other hand, 
even though mammalian cells share functional homologues with the yeasts, some chemicals assayed to 
be non-toxic for S. cerevisiae may be toxic to human cells and tissues. One example of such 
homologies is an inducible multidrug resistance ABC transporter Pdr5p, which is able to export a 
broad range of chemically distinct compounds [10]. Therefore, avoiding long assessment time 
(overnight incubation) will minimize the effects of non-specific inducible efflux pumps that may result 
in underestimation of acute toxicity.  
Previously reported biological acute toxicity assays include bacterial agar plate techniques or assays 
measuring growth inhibition microscopically or spectrophotometrically [6]. On the other hand, yeast 
based assays for toxicity studies have been based on changes of culture respiration [6, 11-15], cell 
growth [16, 17], decreased fluorescence emission by green fluorescence protein (GFP) [18], 
bioavailability of copper and lead [19], or decrease in bioluminescence in the luciferase reporter gene 
assay [20]. Genetically modified yeast cells with human regulatory elements have been successfully 
used also in assessing estrogenicity [7, 21-25] and androgenicity of compounds [26] and detecting cell 
wall-disturbing agents [27].  
In this study we introduce an alternative approach for the assessment of non-specific toxicity of 
several chemicals, even in real-time. Our toxicity assay is based on S. cerevisiae transformed with a 
modified firefly (Photinus pyralis) luciferase gene (luc) as a reporter for genetic response. The luc 
gene is inserted into the plasmid pRS316/GPD-PGK between the constitutive promoter GPD and PGK 
terminator. The plasmid produces light constitutively [21]. Firefly luciferase catalyses the following 
reaction: Luc + D-luciferin + ATP → oxyluciferin + AMP + CO2 + PPi + light. The resulting 
luminescence (yellowish light) can be measured very sensitively in real-time. In our assays, we use D-
luciferin substrate at a pH of 5.0, because in the modified firefly luciferase the last three amino acids of 
the enzyme have been truncated. The natural peroxisomal targeting signal (Ser-Lys-Leu) [28] lacking 
from the C-terminus of the enzyme results in a cytoplasmic expression, which leads to high level of 
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light emission. Under such conditions, where full length firefly luciferase is used [20] D-luciferin must 
traverse cytoplasmic and peroxisomal membranes to give light emission. This together with a D-
luciferin substrate at a pH of 3.0 results in a low level of light emission [20]. We have previously 
shown that keeping the yeast cells at pH of 5.0 increases the light emission and the growth rate, 
providing more viable cells for toxicity measurement [29]. Furthermore, an assay can be done in a 
multi-well plate and the light emission produced by luciferase can be measured simply by adding D-
luciferin substrate after an exposure of few hours or even in real-time. We show in this study that the 
acute toxicity of several model compounds representing completely different kinds of molecular 
families or structures against eukaryotic organisms can now be performed with light-emitting intact 
yeast cells on the contrary to Hollis et al. [20]. 
 
2. Results and Discussion 
 
2.1 Bioluminescence assay 
 
In this work, we estimated the toxicity of selected chemicals by exposing genetically modified yeast 
cells and measuring the luminescence produced in the presence of D-luciferin. In our study, the 
response to different chemicals varied a lot from activation to complete inhibition of light emission 
depending on the concentrations used. The toxicity of two compounds, 5,6-benzoflavone and 
rapamycin were monitored continuously in real-time. According to the results (Table 1), the chemicals 
tested can be divided into toxic or nontoxic for S. cerevisiae.  
 
2.1.1 Antimicrobial agents 
 
Evidently, 5,6-benzoflavone (Table 1) is the most potent among the chemicals tested and 
concidered as toxic for yeast cells. Additionally, a concentration of 750 nM caused total inhibition of 
bioluminescence throughout an exposure of 4 hours and at 7.5 nM the bioluminescence response, 
depending on the exposure time, varied between 41% (after 30 min exposure) of the response in blank 
to 65% of the response in blank (Figure 1a). The results are not unexpected, since 5,6-benzoflavone is 
known to be a strong inducer of certain enzymes belonging to the CYP 450 superfamily and has the 
same induction potency as the carcinogenic benzo(a)pyrene. For this reason 5,6-benzoflavone is 
widely used for studies in toxic effects in mammals mediated by aryl hydrocarbon receptor [30]. On 
the other hand as far as we know, no data in the literature on non-specific toxicity measured by a yeast-
based bioassay is available for 5,6-benzoflavone.  
We also obtained interesting results in an exposure of rapamycin (shown in Figure 1b as an 
example). It is clearly evident that the toxicity of 5,6-benzoflavone (Figure 1a) and rapamycin (Figure 
1b) can be followed in real-time after the administration of the toxicant and the luciferase substrate  
D-luciferin. The emission is dose-dependent and the toxicity can be followed kinetically inside the 
thermostated measurement chamber of the multilabel reader. 
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Table 1. The IC50 values (µmol/L) of the chemicals measured by the bioluminescence 
assay having the exposure of 2.5 h or 5 h compared to the results (minimum inhibitory 
concentration, µmol/L) of the conventional agar diffusion assay.  
Compound 
Bioluminescence assay 
IC50 (µmol/L) Agar diffusion assay 
Exposure time 
2.5 h 
Exposure time 
5 h 
Minimum inhibitory 
concentration (MIC) 
(µmol/L) 
Antimicrobial agents    
5,6-benzoflavone 0.008 0.006 0.075 
Cycloheximide NTa 0.7 42.7 
Ketoconazole NT NT 1.0 
Nystatin 1.6 1.4 54.0 
Rapamycin 2.8 0.03 0.2 
Sodium azide 25.8 27.4 - b 
Sodium dodecyl sulfate 133.5*103 69.5*103 1.8*103 
 
Metals    
Arsenic(V)oxide 2.4*103 0.4*103 85.5*103 
Sodium-m-arsenite 25.5*103 0.5*103 14.5*103 
Cadmium(II)chloride 19.3*103 2.0*103 124.6*103 
Copper(I)sulfate 5.1*103 ND 9.8*103 
Lead(II)acetate 71.9*103 18.4*103 - c 
Magnesium(II)chloride NT NAd 2060.5*103 
Zinc(II)chloride NT NA 10265.6*103 
 
a
 NT, not toxic, the IC50–level not reached, b no growth visible at the assay plate, c the 
sample precipitated on the plate, d NA, not assayed 
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Figure 1a. Bioluminescence response to 5,6-benzoflavone in real-time monitoring during 
exposure of 4 h. Squares (0.75 nM), diamonds (7.5 nM), circles (75 nM) and triangles 
(750 nM) denote for concentration of 5,6-benzoflavone used, respectively. The error bars 
are shown for triplicate parallel measurements. 
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Figure 1b. Bioluminescence response to rapamycin in real-time monitoring during an 
exposure of 4h. Rapamycin reveals totally different bioluminescence response. The error 
bars are shown for triplicate parallel measurements and the symbols are diamonds (0.05 
µM), Squares (0.5 µM), and circles (5 µM) denote for concentration of rapamycin used, 
respectively. 
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The bioluminescence responses to nystatin (Figure 2) were different from the responses to other 
tested chemicals. Low concentrations of nystatin had no inhibitory effect on the yeast sensor cells; the 
light production was similar to that of the blank (100%). At a concentration of 0.54-1.08 µM, the 
bioluminescence response, depending on the exposure time, varied between 290% (an exposure of 5 
hours) and 371% (an exposure of 2.5h), while a concentration of 5.40 µM caused total inhibition of 
bioluminescence and can be considered as toxic for the yeast sensor. After an exposure of 10 hours, the 
peak values at low concentrations of nystatin were not visible any more. This effect was seen 
repeatedly and was statistically significant in the control experiments. One explanation for this odd 
behaviour could be due to nonspesific, uncharacterized inhibition of metabolic pathways leaving more 
ATP to be used for the luciferase reaction. Thus, the phenomenom may be explained by mechanism of 
nystatin. This antifungal agent interacts with membrane sterols and damages cell membranes thus 
causing the leakage of intracellular K+ and increased permeability to protons [32]. Maybe excess of 
protons are used by vacuolar membrane H+-ATPases [33] to generate ATP which can be seen as a 
peak in a narrow concentration area. Similar high peak of ATP concentration has been observed in 
yeast cells during the lag growth phase, while in the logarithmic growth phase the amount of ATP 
remained constant being 2 µmol ATP/g yeast [34]. Another explanation would be minor increases in 
transcription of specific genes related to stress responses or modes of action as described for bacteria 
[35, 36]. The luminescence peak has also been characterized previously in bacterial reporter gene 
systems [37]. 
 
Figure 2. The bioluminescence response to nystatin, exposure of 2.5, 5 and 10 h. Squares 
(2.5 h), circles (5 h) and diamonds (10 h) denote for exposure used, respectively. The 
error bars are shown for triplicate parallel measurements. 
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Sodium dodecyl sulfate (SDS) is an anionic detergent (surfactant) that is commonly used in 
household detergents and in various industrial and academic applications. In our studies, a 
concentration of 133.5 mM caused a 50% decrease in luminescence after a 2.5 h of exposure, while 
after a 5 h of exposure the same effect was seen at a concentration of 69.5 mM (Table 1). The increase 
in toxicity may be due to a prolonged exposure. SDS has more time to damage membrane structure 
and solubilizes proteins. [38]. 
Our results contradict those by Sirisattha et al. [38], where exposing yeast cells to 0.01% (34.7 mM) 
SDS for 2 h caused damages to membrane structure, altered carbon metabolism and induced oxidative 
stress in yeast cells. The difference could be partially attributed to different assay methods or 
experimental conditions. Our toxicity assay is based on S. cerevisiae transformed with a modified 
firefly luciferase gene as a reporter for genetic response. The bioluminescence produced by luciferase 
can be measured in intact living cells by adding the D-luciferin substrate after an exposure. In their 
studies, Sirisattha et al. used microarrays monitoring gene expressions. The yeast strain (also different 
from ours) was cultivated in a different medium and total RNA was extracted. Additionally, the 
incubation temperatures differed.  
Interesting and unexpected results (Table 1) were also obtained by exposing the yeast sensor cells to 
cycloheximide (a protein synthesis inhibitor). An exposure of the yeast sensor cells to ths compound 
for 2.5 h had no toxic effects, while an exposure of 5 h was highly toxic. At the beginning of 
incubation, a MFS efflux pump can remove the drug from its cellular targets to vacuoles resulting in 
increased resistance [39], while under a prolonged exposure the vacuolar capacity is insufficient in 
preventing cycloheximide to concentrate in a cytosol. Additionally, beside the MFS efflux pump, 
cycloheximide resistance is induced by an efflux pump belonging to the ABC superfamily. Possibly, 
the latter efflux pump like Pdr5p is strongly expressed during the exponential growth phase, whereas 
during the stationary growth phase or limitations of important nutrients the expression level of the 
efflux pump rapidly decreases [40] thereby, making the yeast cells more susceptible to cycloheximide. 
The results show that at least 1000-fold increase in toxicity with increasing exposure time was 
observed for cycloheximide (the highest concentration tested was 0.43 mM). Ten or more-fold increase 
in toxicity with increasing exposure time was observed for rapamycin, arsenic(V)oxide, sodium-m-
arsenite and cadmium(II)chloride, whereas 5,6-benzoflavone, ketoconazole, nystatin, sodium azide and 
SDS showed no increase (Table 1, paragraph 2.2). An increase in sensitivity after a 5 hours exposure 
time may be due to changes during the growth phase of the sensor yeast. One of the most important 
changes concerning the drug resistance is probably the altered expression of multidrug efflux pumps or 
protein transporters belonging to the ABC transporters or members of the major facilitator superfamily 
(MFS) that can transfer a wide range of chemically dissimilar compounds with different affinity to the 
extracellular space thus conferring the pleiotropic (or multidrug) drug resistance (PDR) [41]. Some of 
these efflux pumps are plasma membrane proteins like the most studied Pdr5p. Moreover, a vacuolar 
membrane efflux pump such as the glutathione S-conjugate transporter that confers resistance to 
arsenite, cadmium and lead is known [42]. Efflux pumps are noticed to be activated in an early stage 
by external stress. For example, Pdr5p was induced only after a 4 minutes of exposure to benomyl [43] 
and was strongly expressed during the exponential growth phase, while during the stationary growth 
phase Pdr5p levels decreased rapidly. Additionally, Pdr5p needs glucose for functioning and the 
limitation of glucose or other important nutrients such as nitrogen reduces Pdr5p expression [40]. 
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2.1.2 Heavy metals 
 
Table 1 shows that even at the millimolar concentrations the heavy metals such as arsenic 
compounds, cadmium chloride and lead acetate had little if any non-specific toxicity to S. cerevisiae, 
although toxic effects were shown to increase slightly with increasing exposure time at the tested 
concentrations. These results were expected, as S. cerevisiae has been known to have mechanisms for 
detoxification and heavy metal resistance: efflux that is an active extrusion of the heavy-metal ion 
from the cell, accumulation into vacuoles as glutathione conjugates and reduction to a less toxic 
oxidation state [44]. To produce the resistance to arsenite, S. cerevisiae has two independent transport 
systems: a plasma membrane transporter and a vacuolar membrane transporter that belongs to the ABC 
transporter superfamily. Thus arsenite ions are extruded from a cytosol or accumulated into vacuoles 
as glutathione conjugates that require glutathione as a reductant [45]. Moreover, resistance to cadmium 
and lead is due to the same glutathione S-conjugate transporter [42]. 
In our experiment, trace elements, such as copper sulfate, zinc- and magnesium- chloride were little 
or non toxic to S. cerevisiae and zinc- and magnesium- chloride even increased the signal intensity and 
improved the health of the yeast cells at the tested concentrations. This was expected, because Cu and 
Zn are biologically essential trace elements and a component in a variety of enzymes and DNA-
binding proteins [42].  
 
2.2 Agar diffusion assay compared to bioluminescence assay 
 
To compare and validate the results from the bioluminescence assay, a conventional agar diffusion 
assay (ADA) was performed. Toxicity of the selected chemicals was estimated by spotting the test 
sample in filter papers (Ø 6 mm) on the surface of the agar plates containing logarithmic grown yeast 
sensor strain and then measuring the growth inhibition zones after overnight incubation at 30 ˚C. The 
lowest chemical concentration at which an inhibition zone could be observed was defined as a value of 
minimal inhibitory concentration (MIC).  
The results (Table 1 and Figure 3) showed correlation with the results from the bioluminescence 
assay. In general, the toxic chemicals showed toxicity in the ADA, whereas the ones predicted to be 
nontoxic had no toxic effects. Ketoconazole was an exception showing toxic effects to the yeast sensor 
strain in the ADA but having no significant response in the bioluminescence assay. To improve 
solubility ketoconazole was dissolved into acetate buffer (pH 3.6). However, better solubility does not 
necessarily mean increased bioavailability. Ketoconazole is an antifungal drug that contains imidazole 
and piperazine parts. For cellular uptake they both should be in a nonprotonated form which happens 
in a neutral environment [46]. Maximal uptake of ketoconazole by the human pathogenic yeast 
Candida albicans occurs between pH 6.5-7, while in an acidic environment ketoconazole penetrates 
into yeasts poorly. It has been suggested that even 200-fold increase in sensitivity towards Candida 
albicans has been reached as pH increases from 3 to 5 [47]. Thus, ketokonazole having no significant 
response in the bioluminescence assay could be partly explained by a low pH 3.6 of the solvent used. 
The other explanation might be an expression of PDR pumps induced by weak acid stress. During the 
normal yeast metabolism pH of as low as 3 (data not shown) is achieved because of acetate 
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production.This weak acid stress induces certain PDR pump that extrudes acetate from yeast cells 
thereby preventing penetration of external acetate [41]. However, in the ADA the inhibitory effect of 
ketoconazole was observed. This could be attributed to longer incubation time (1-3 days) compared to 
the bioluminescence assay. The yeasts are in the late stationary phase, in which the expression level of 
efflux pumps decreases [40] thereby making the yeast cells more susceptible to ketoconazole.  
Concerning the bioluminescence assay, sodium azide was highly toxic (Table 1), however, no 
visible growth was detected in the ADA throughout the plate containing the highest sodium azide 
concentration (Figure 3a) and moreover, no clear inhibition zones in the plate containing more dilute 
sodium azide solutions (Figure 3b) are visible. These observations indicate that sodium azide with 
molecular weight of 65.01 g/mol is such a small molecule that it is assumed to diffuse equally into 
agar, inhibiting growth totally. As we have shown here, a traditional toxicity assay on agar plates is not 
a convenient method in measuring toxicity of very small molecules in a yeast toxicity assessment. 
 
Figure 3. Toxicity assay on agar plates. A plate containing stronger sodium azide 
solution (a) has no visible growth, whereas in one containing more dilute sodium azide 
solutions (b) no clear inhibition circles are visible. A plate containing nystatin solutions 
(c) is a good example of toxicity assay with clear inhibition zones. 
 
 
 
 
 
a 
b 
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3. Experimental Section  
 
3.1 Chemicals 
 
Zinc(II)chloride (ZnCl2), cadmium(II)chloride (CdCl2), lead(II)acetate [(CH3COO)2Pb], sodium 
azide (NaN3) and 30% hydrogen peroxide were from Merck & Co (Whitehouse Station, NJ, USA), 
sodium-m-arsenite (NaAsO2), nystatin (C47H75NO17), sodium dodecyl sulfate (SDS, C16H25OSO3Na) 
and 5,6-benzoflavone (B-NF, C2H6OS), dimethyl sulfoxide (DMSO), trisodium citrate, adenine 
hemisulfate salt, l-leucine, l-histidine and l-tryptophan from Sigma-Aldrich Co (St. Louis, MO, USA), 
Copper(I)sulfate (CuSO4) was from VWR International (West Chester, PA, USA), 
magnesium(II)chloride (MgCl2) from Mallinckrodt Baker (Phillipsburg, NJ, USA), arsenic(V)oxide 
(As2O2) and citric acid (Fluka) from Sigma-Aldrich Co (St Louis, MO, USA) and cycloheximide from 
MP Biomedicals (Aurora, OH, USA). Ethanol was from Altia Plc (Helsinki, Finland), antibiotic assay 
disks of diameter of 6 mm were from Schleicher & Schuell (Keene, NJ, USA). Yeast nitrogen base w/o 
amino acids and agar-agar (Difco) were purchased from Voigt Global Distribution (Lawrence, KS, 
USA) and D-Luciferin was supplied by Biothema AB (Handen, Sweden). 
 
3.2 Sample preparation 
 
Stock solution from each test chemical was prepared by dissolving the solid chemical into the 
following solvent: ketoconazole was dissolved into acetate buffer (pH 3.6) nystatin and B-NF into 
DMSO. Other chemicals were dissolved into sterile deionized water. Sample sets were prepared by 
diluting stock solutions in a ratio of 1:10 with the respective solvent. Rapamycin solutions were stored 
at -20˚C and CdCl2, NaN3, As2O2, NaAsO2, cycloheximide, nystatin, ketoconazole and B-NF solutions 
were stored at +4˚C. Other samples were preserved at room temperature and protected from light.  
 
3.3 Yeast strain cultivation 
 
The yeast strain used in this study was S. cerevisiae transformed with a modified firefly (Photinus 
pyralis) luciferase gene (luc) inserted in the plasmid as a reporter for genetic response, BMA64-
1A+pRS316luc [29]. The insertion into this plasmid facilitates the incorporation of the reporter gene 
into the chromosome of S. cerevisiae. Firefly luciferase catalyses the following reaction: Luc + 
D-luciferin +ATP → oxyluciferin + AMP + CO2 +PPi + light. The resulting luminescence (yellowish 
light) can be measured very sensitively and in our assay simply by adding D-luciferin substrate after an 
exposure of few hours or even in real-time. We use the D-luciferin substrate at pH of 5.0, because in 
the modified firefly luciferase the last three amino acids of the enzyme have been truncated. The 
natural peroxisomal targeting signal (Ser-Lys-Leu) [28] lacking from C-terminus of the enzyme results 
in cytoplasmic expression, which leads to high levels of light emission.  
For both bioluminescence and conventional agar diffusion assay, S. cerevisiae was cultivated 
overnight at 30˚C and 300rpm shaking in liquid synthetic dextrose medium (SD) that contains yeast 
nitrogen base w/o amino acids (6.7 g/L) and D-glucose 40 mL/L of a 40% (w/v) supplemented with 
adenine (5 g/L) and the essential amino acids l-histidine (2 g/L), l-leucine (10 g/L) and l-tryptophan (2 
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g/L). Yeast nitrogen base w/o amino acids and D-glucose were autoclaved (121°/15 min) and adenine 
and amino acids were filter sterilized (pore size 0.2 µM). pH of the SD medium was checked time to 
time and pH was 4.8±0.2. For the bioluminescence assay, the yeast cells were grown to an optical 
density (OD600) of about 3.0 and after that the culture was diluted with the same medium to OD600 of 
0.8 and right after were used in the assay. For agar diffusion assay, the same medium described above 
was solidified with agar-agar. 
 
3.4 Assay procedures 
 
3.4.1 Bioluminescence assay 
 
Ten or 1 µL aliquots of the sample sets and reference samples (blank solvent) were pipetted in 
triplicate into a white 96-well plate (Thermo Electron Corporation, Finland) with hydrogen peroxide 
(0.3% or 3%, depending on the test) as a positive control. Ninety or 100 µL aliquots of the diluted 
yeast culture were then added into the wells containing samples. In the wells, the final amount of water 
or acetate buffer was 10 % and DMSO 1%. 
Plates were then incubated at 30˚C and 300 rpm for 2.5 h or 5 h. After the incubation, 100 µL 
aliquots of 1 mM D-luciferin (in 0.1 M Na-citrate buffer pH 5) were pipetted into the wells and the 
bioluminescence was immediately measured with a Chameleon Multilabel Detection Platform (Hidex 
Oy, Turku, Finland). Furthermore, for real-time monitoring, 5,6-benzoflavone and rapamycin were 
measured continuosly (Figure 1) and light emission level of the blank, expressed as relative light units 
(RLU) was set as 100%. The IC50 of all tested chemicals was calculated. Because the bioluminescence 
response curves of nystatin were different from the curves of other tested chemicals, an exposure time 
of 10 hours was used to see if the same phenomenon could be seen under a prolonged incubation time.  
 
3.4.2 Agar diffusion assay 
 
To compare and validate the results from the bioluminescence assay, a conventional agar diffusion 
assay (ADA) was performed. Aliquots of test sample (five dilutions) and reference solutions were 
pipetted onto filter papers (Ø 6 mm) which were then spotted on the surface of the SD –agar plates 
containing the logarithmic overnight grown yeast sensor strain. After overnight incubation at 30 ˚C, 
the growth inhibition zones were measured. The lowest chemical concentration at which an inhibition 
zone could be observed was defined as a value of minimal inhibitory concentration (MIC).  
 
4. Conclusions  
 
The goal of this study was to show that our toxicity assay based on a representative of eukaryotic 
cells S. cerevisiae transformed with a modified firefly (Photinus pyralis) luciferase gene (luc) inserted 
in the plasmid as a reporter is an alternative method in screening non-specific toxicity of several 
chemicals in real-time. The toxicity of the test compounds was assessed in the bioassays based on 
bioluminescence inhibition. The traditional growth inhibition on an agar plate was performed to 
compare and validate the results from the bioluminescence assay. 
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It naturally needs to be emphasized that when toxicity testing is concerned, all systems have their 
advantages and disadvantages. Even though the results from the agar diffusion assay (ADA) correlated 
with the results from the bioluminescence assay, the ADA has many disadvantages. Making plates for 
each concentrations and each chemical is time-consuming, and the results can be read only after 1-3 
days, whereas in the bioluminescence assay different concentrations of different chemicals can be 
performed in a multi-well plate and the luciferase activity can be measured from intact living yeast 
cells even in real-time just by adding D-luciferin. Furthermore, since the ADA reveals only a level of 
the toxicity, the bioluminescence assay can give some ideas about the character of the toxicity like 
during 5,6-benzoflavone, rapamycin and nystatin monitoring. Thus, because of the advantages 
mentioned above and due to the fact that S. cerevisiae is easy to cultivate in a pour medium with short 
generation time, the bioluminescence assay could be a fast and inexpensive tool suitable for toxicity 
assessments.  
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